# Trade Mark Journal No.2026/017 24 April 2026

## WO0000001911868 (5,42,45)

Office of origin: United States of America

Date of International Registration:27 October 2025
Date of designation in the UK: 27 October 2025

International priority date claimed: 14 May 2025 (United States of America) (99185289)

Class 5
  Pharmaceutical preparations, namely a drug delivery system in the form of water-soluble prodrugs that facilitate the solubility of a wide range of pharmaceuticals; drug carriers for medical use consisting of molecules that increase water-solubility of compounds for oral delivery of therapeutically active chemical compounds for human use.
Class 42
  Research and development services in the field of water-soluble drug delivery technologies; Providing product development in the fields of drug delivery systems, small molecules, peptides, pharmaceuticals, and medicine; providing technological information in the fields of drug delivery systems, small molecules, peptides, pharmaceuticals, and medicine.
Class 45
  Licensing of technology in the field of pharmaceuticals, medicine, and biotechnology; licensing of chemical reagents and water-soluble pharmaceutical products; licensing of patents and patent applications.

Salacia Therapeutics, Inc.

Representative: Chelseaa Larsen Sheppard Mullin Richter & Hampton, LLP, 1540 El Camino Real, Suite 120, Menlo Park CA 94025, UNITED STATES OF AMERICA